Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer.

被引：0
|
作者：
Muendlein, Axel
Rhode, Bettina
Gasser, Klaus
Kinz, Elena
Drexel, Heinz
Hofmann, Wera
Schindler, Verena
Kapoor, Rita
Decker, Thomas
Lang, Alois
机构：
[1] Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria
[2] GATC, Constance, Germany
[3] Acad Teaching Hosp Feldkirch, Feldkirch, Austria
[4] VIVIT, Feldkirch, Austria
[5] GATC Biotech AG, Constance, Germany
[6] Onkol Ravensburg, Ravensburg, Germany
[7] Acad Teaching Hosp, Feldkirch, Feldkirch, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1119
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BRCA1 MUTATION AND ITS PROGNOSTIC ROLE IN THE TRIPLE-NEGATIVE BREAST CANCER (TNBC) SUBTYPE
    Maksimenko, J. J.
    Irmejs, A.
    Trofimovics, G.
    Miklasevics, E.
    [J]. BREAST, 2013, 22 : S32 - S33
  • [22] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Arisa Morizono
    Masahiko Tanabe
    Masako Ikemura
    Takeshi Sasaki
    Tetsuo Ushiku
    Yasuyuki Seto
    [J]. Journal of Human Genetics, 2021, 66 : 785 - 793
  • [23] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Morizono, Arisa
    Tanabe, Masahiko
    Ikemura, Masako
    Sasaki, Takeshi
    Ushiku, Tetsuo
    Seto, Yasuyuki
    [J]. JOURNAL OF HUMAN GENETICS, 2021, 66 (08) : 785 - 793
  • [24] BRCA1 mutation in the Triple- Negative Breast Cancer Group
    Jelena Maksimenko
    Arvids Irmejs
    Genadijs Trofimovics
    Edvins Miklasevics
    [J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 4)
  • [25] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [26] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    [J]. Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [27] Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer
    Danzinger, Sabine
    Tan, Yen Yen
    Rudas, Margaretha
    Kastner, Marie-Theres
    Weingartshofer, Sigrid
    Muhr, Daniela
    Singer, Christian F.
    [J]. CANCER INVESTIGATION, 2018, 36 (07) : 378 - 388
  • [28] BRCA1 gene expression signature predicts for anthracycline-chemosensitivity in triple-negative breast cancer.
    Rodriguez, A. A.
    Makris, A.
    Harrison, M. K.
    Ostler, P. J.
    Froehlich, A.
    Pavlick, A.
    Wong, H.
    Tsimelzon, A.
    Sexton, K.
    Hilsenbeck, S. G.
    Lewis, M. T.
    Rimawi, M.
    Osborne, C. K.
    Chang, J. C.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 358S - 358S
  • [29] High rates of BRCA1 and BRCA2 germline mutations among Arab patients with triple-negative breast cancer
    Abdel-Razeq, Hikmat
    Abujamous, Lama
    Bater, Rayan
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [30] Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis
    Tun, N. M.
    Villani, G.
    Ong, K.
    Yoe, L.
    Bo, Z. M.
    [J]. CLINICAL GENETICS, 2014, 85 (01) : 43 - 48
12345